12
M. Ashfaq et al. / Inorganic Chemistry Communications 14 (2011) 5–12
(CDCl3): C-1: 171.31; C-2: 56.98; C-3: 48.83; C-4: 11.13; C-a: 27.62; C-b: 26.65; C-c:
27.04; C-d: 14.98.119Sn NMR (CH3)4Sn: −133.11.Compound
TPhTNNDEG,
solvent: chloroform, mp: 123–125 °C, yield: 83%, solubility: soluble in chloroform,
6
ethanol and methanol, insoluble in other organic solvents and water.CHN
analysis (%)antipyrene: C: 62.69(62.71), N: 2.59 (2.61), H: 6.57 (6.58).IR analysis
(cm−1): CO(carbonyl): 1630asym, 1504sym sb, C_N: 1529(b) CO (ether linkage):1076
(s) Δν: 126, Sn–O: 734 sp, Sn–C: 574 w.sp.1H NMR (CDCl3): H-2: 3.23 s; H-3: 2.64 t
(7.2 Hz); H-4, -5: 2.34–2.59 m; H-6: 0.93 t (7.2 Hz); H-b, -c,-d: 7.27–7.14 m.13C NMR
(CDCl3): C-1: 175.23; C-2: 59.95; C-3: 55.24; C-4: 29.19; C-5: 21.15; C-6: 15.51; C-a:
134.96 [1 J(119Sn–13C)=649 .6]; C-b: 134.76 2 J (119Sn–13C)=46 .6]; C-c: 27.97 3 J
[(C6H5)3SnOOCCH2N(C2H5)2] was re-crystallized in chloroform, mp: 133–135 °C,
yield: 88%, soluble in chloroform, methanol and ethanol, insoluble in other
organic solvents and water.CHN analysis (%)antipyrene: C: 60.01(60.03), N: 2.90
(2.92), H: 5.66 (5.67). AAS analysis(%): Sn: 24.70 (24.72).IR analysis (cm−1): CO
(carbonyl): 1631asym, 1507sym sb, C_N: 1537(b) CO (ether linkage):1069 (s) Δν: 124,
Sn–O: 738 sp, Sn–C: 571 w.sp.1H NMR (CDCl3): H-2: 3.33 s; H-3: 2.65 q (7.2 Hz); H-
4: 1.05 t(7.2 Hz); H-b, -c, -d: 7.61–7.23 m.13C NMR (CDCl3): C-1: 172.39; C-2: 57.87;
C-3: 48.22; C-4: 11.19; C-a: 134.15 [1 J (119Sn–13C)=648 .9]; C-b: 132.51 [2 J (119Sn–
13C)=48 .7]; C-c: 131.16 [3 J (119Sn–13C)=64.8]; C-d: 129.16.119Sn NMR (CH3)4Sn:
−124.22.Compound 7 TCyTNNDEG, [(C6H11)3SnOOCCH2N(C2H5)2] was re-crystal-
lized in chloroform, mp: 141–142 °C, yield: 77%, soluble in chloroform, methanol and
ethanol, insoluble in other organic solvents and water. When six fold of water was
added its alcoholic solution remained clear.CHN analysis (%) antipyrene: C: 57.83
(57.84), N: 2.79 (2.81), H: 9.09 (9.10).IR analysis (cm−1): CO(carbonyl): 1653asym,
1529sym sb, C_N: 1534(b) CO (ether linkage):1078 (s) Δν: 124, Sn–O: 748 sp, Sn–C:
564 w.sp.1H NMR (CDCl3): H-2: 3.34 s; H-3: 2.89 q (7.2 Hz); H-4: 1.05 t (7.2 Hz); H-
a: 1.10 t (7.2 Hz); H-b: 1.36 q (7.2); H-c, -d: 1.31-1.23 m.13C NMR (CDCl3): C-1:
167.63; C-2: 58.01; C-3: 48.41; C-4: 11.11; C-a: 23.77; C-b: 27.641; C-c: 28.71; C-d:
25.04.119Sn NMR (CH3)4Sn: 74. 24.Compound 8 DBTNNDBG (monomer), [(C4H9)2-
NCH2COO]2SnBu2 was re-crystallizede in chloroform and ethanol 1:2 ratio, mp: 40 °
C, yield: 89%, solubility: soluble in chloroform, methanol and ethanol.CHN analysis
(%) antipyrene: C: 56.83 (56.85), N: 4.41 (4.42), H: 9.79 (9.86).IR analysis (cm−1):
CO(carbonyl): 1630 asym 1510 sym sb, C_N: 1530 (b) CO (ether linkage):1070 (s) Δν:
120. Sn–C: 545 w.sp; Sn–O: 720 sp.1H NMR (CDCl3): H-2: 4.05 s; H-3: 2.61 t (7.2); H-
4: 1.62-1.67 m; H-5: 1.32-1.27 m; H-6: .096 t (7.2 Hz);H-a: 1.25 t (7.1 Hz); H-b, -c:
1.36-1.40 m; H-d: 0.89 t (7.2 Hz).13C NMR(CDCl3): C-1:175.37; C-2: 59.08; C-3:
56.35; C-4: 29.21; C-5: 21.71; C-6: 15.51; C-a: 28.72; C-b: 28.87; C-c: 27.42; C-d:
13.05.119mSn Mössbauer data (mm s−1): QS: 3.38; IS: 1.31; G1: 0.86; G2: 0.84;
δ=QS/IS: 2.58.119Sn NMR (CH3)4Sn: −191. 22.Compound 9 DBTNNDBG (dimer),
[{(C4H9)2NCH2COOSnBu2}2O]2 was re-crystallized in chloroform and ethanol 1:2,
mp: 50 °C, yield: 81%, soluble in chloroform, methanol and ethanol on heating.CHN
analysis (%) antipyrene: C: 52.55 (52.72), N: 2.79 (2.81), H: 6.23 (6.24). IR analysis
(cm−1): CO(carbonyl): 1639asym 1517sym sb, C_N: 1532 (b) CO (ether linkage):1077
(s) Δν: 122. Sn–C: 576 w.sp; Sn–O: 715 sp.1H NMR (CDCl3): H-2: 4.25 s; H-3: 2.51 t
(7); H-4: 1.53-1.59 m; H-5: 1.29-1.25 m; H-6: 0.94 t (7.2 Hz); H-a: 1.02t (7.2 Hz); H-
b: 1.52 t (7.1 Hz); H-c: 1.25 q (7.2 Hz); H-d: 0.91t (7.2 Hz).13C NMR(CDCl3): C-1:
175.37; C-2: 59.08; C-3: 56.35; C-4: 29.21; C-5: 21.71; C-6: 27.3; C-a: 28.64; C-b:
27.67; C-c: 25.12; C-d: 14.91.119mSn Mössbauer data (mm s−1): QS: 3.58; IS: 1.53;
G1: 0.87; G2: 0.82; δ = QS/IS: 2.34.119SnNMR(CH3)4Sn: -199.72, -225.15.Compound
10: TBzTNNDBG, [(C6H4CH2)3SnOOCCH2N(C4H9)2].Re-crystallizing solvent: chloro-
form, mp: 117–118 °C, yield: 80%, solubility: soluble in chloroform, ethanol and
methanol, insoluble in other organic solvents and water.When seven fold of water
was added its alcoholic solution remained clear.CHN analysis (%)antipyrene: C:
66.67 (66.68), N: 2.41 (2.43), H: 7.51 (7.52).IR analysis (cm−1): CO(carbonyl):
1645asym 1521sym sb, C_N: 1529 (b) CO (ether linkage):1067 (s) Δν: 124, Sn–O: 725
sp, Sn–C: 556 w.sp.1H NMR (CDCl3): H-2: 4.50 s; H-3: 2.91 t (7.2 Hz); H-4: 2.42-
2.44 m; H-5: 2.34-2.35 m; H-6: 0.95 t (7.2 Hz); H-a: 2.80 s; H-c, -d, -e: 7.23–
7.04 m.13C NMR (CDCl3): C-1: 174.91; C-2: 61.64; C-3: 54.48; C-4: 28.19; C-5: 23.71;
C-6: 15.51; C-a: 22.45; C-b: 135.63; C-c: 125.67; C-d: 127.84; C-e: 123.98.119Sn NMR
(CH3)4Sn: −155.15.Compound 11 DBzTNNDBG, [(C6H4CH2)2Sn{OOCCH2N
(C4H9)2}2] was solidified in chloroform, mp: 210–212 °C, yield: 78%, soluble in
chloroform, methanol and ethanol, DMSO insoluble in other organic solvents and
water. When eight foldof waterwasadded its alcoholic solution remainedclear. CHN
analysis (%)antipyrene: C: 64.12 (64.13), N: 4.26 (2.27), H: 8.59 (8.61).IR analysis
(cm−1): CO(carbonyl): 1636asym, 1517sym sb, C_N: 1530 (b) CO (ether linkage):1061
(s) Δν: 119, Sn–O: 730 sp, Sn–C: 570 w.sp.1H NMR (CDCl3): H-2: 3.46 s; H-3: 2.71 t
(7.2 Hz); H-4, -5: 2.32–2.25 m; H-6: 0.96 t (7.2 Hz); H-a: 2.71 s; H-c, -d, -e: 7.2–
7.34 m.13C NMR (CDCl3): C-1: 175.31; C-2: 62.44; C-3: 55.88; C-4: 29.29; C-5: 23.55;
C-6: 16.51; C-a: 21.44; C-b: 136.33; C-c: 126.16; C-d: 128.44; C-e: 124.88.119Sn NMR
(CH3)4Sn: −266.12.Compound 12 TBTNNDBG, [(C4H9)3SnOOCCH2N(C4H9)2] was
solidified in n-hexane, mp: 145–147 °C, yield: 89%, soluble in chloroform, soluble in
ethanol on heating, slightly soluble in methanol and insoluble in water.CHN analysis
(%)antipyrene: C:55.45(55.47), N: 2.93 (2.94), H: 9.94 (9.95).IR analysis (cm−1): CO
(carbonyl): 1644asym, 1519sym sb, C_N: 1528 (b) CO (ether linkage):1065 (s) Δν: 125,
Sn–O: 732 sp, Sn–C: 577 w.sp.1H NMR (CDCl3): H-2: 4.61 s; H-3: 2.98 t (7.2 Hz); H-4,
-5: 2.37–2.45 m; H-6: 0.95 t (7.2 Hz); H-a: 0.81 t (7.2 Hz); H-b, -c: 1.12–0.98 m; H-d:
0.96 t (7.2 Hz).13C NMR (CDCl3): C-1: 181.31; C-2: 62.44; C-3: 55.88; C-4: 29.29; C-5:
21.54; C-6: 16.51; C-a: 28.56; C-b: 26.98; C-c: 27.97; C-d:14.88.119SnNMR (CH3)4Sn:
-139.71.Compound 13: TPhTNNDBG, [(C6H5)3SnOOCCH2N(C4H9)2].Re-crystallizing
(
119Sn–13C)=66.6); C-d: 131.74.119Sn NMR (CH3)4Sn: −127.87.Compound 14
TCyTNNDBG, [(C6H11)3SnOOCCH2N(C4H9)2].Re-crystallizing solvent: chloroform,
mp: 120–121 °C, yield: 87%, solubility: soluble in chloroform, ethanol and methanol,
insoluble in other organic solvents and water.When six fold of water was added its
alcoholic solution remained clear.CHN analysis (%)antipyrene: C: 60.64(60.66), N:
2.51 (2.53), H: 9.63 (9.64).IR analysis (cm−1): CO(carbonyl): 1632asym, 1508sym sb,
C_N: 1534(b) CO (ether linkage):1078 (s) Δν: 124, Sn–O: 738 sp, Sn–C: 578 w.sp.1H
NMR (CDCl3): H-2: 3.54 s; H-3: 2.69 t (7.2 Hz); H-4, -5: 1.55 -1.59 m; H-6: 0.95 t
(7.2 Hz); H-a: 1.25 t (7.2 Hz); H-b: 1.61; H-c: 1.41; H-d: 1.45.13C NMR (CDCl3): C-1:
170.43; C-2: 59.23; C-3: 55.14; C-4: 29.19; C-5: 20.17; C-6: 14.11; C-a: 23.44; C-b:
27.4; C-c: 29.96; C-d: 20.06.119Sn NMR (CH3)4Sn: 82.34.
[23] [a] M. Gielen, Main Group Met. Chem. 20 (8) (1997) 535;
[b] G.de.M. Lima, D.J. Duncalf, S.P. Constantine, Main Group Met. Chem. 24 (2001)
675.
[24] C.C. Camacho, D. de. Vos, B. Mahieu, M. Gielen, M. Kemmer, M. Biesemans, R.
Willem, Main Group Met. Chem. 23 (2000) 381.
[25] M. Gielen, A.E.L.C. Khloufi, M. Biesemans, F. Kayser, R. Willem, Appl. Chem. 7
(1993) 201.
[26] L. Ronconi, C. Marana, U. Russo, S. Sitran, R. Graziani, D. Fregona, J. Inorg. Biochem.
91 (2002) 413.
[27] M. Ashfaq, A. Majeed, M.K. Baloch, A.W.K. Khanzada, W.U. Shah, J. Chinese Chem.
Soc. 50 (3A) (2003) 361.
[28] J.C. Martins, R. Willem, F.G. Mercier, M. Gielen, M. Biesemans, J. Am. Chem. Soc.
121 (1999) 328.
[29] R. Willem, H. Dalil, M. Biesemans, J.C. Martins, M. Gielen, Appl. Organomet. Chem.
13 (1999) 605.
[30] H. Dalil, M. Biesemans, M. Teerenstra, R. Willem, L. Angiolini, E. Salatelli, D. Caretti,
Macromol. Chem. Phys. 201 (2000) 1266.
[31] M. Gielen, Appl. Organomet. Chem. 16 (2002) 481.
[32] M. Kemmer, L. Ghys, M. Gielen, M. Biesemans, E.R.T. Tiekenk, R. Willem,
J. Organomet. Chem. 582 (1999) 195.
[33] J.M. Hook, B.M. Linahan, R.L. Taylor, E.R.T. Tiekink, L. Van, L.K. Gorkom, Webster,
Main Group Met. Chem. 17 (1994) 293.
[34] R. Barbieri, F. Huber, L. Pellerito, G. Ruisi, A. Silvestri, Tin-119 m Mo¨ssbauer
Studies on Tin Compounds, in: P.J. Smith (Ed.), Chemistry of Tin, Chapman and
Hall, London, 1998, p. 496, (Chapter 14).
[35] M. Gielen, T. Mancilla, J. Rambarter, R. Willem, J. Organomet. Chem. 328 (1987) 61.
[36] M. Kemmer, L. Ghys, M. Gielen, M. Biesemans, E.R.T. Tiekenk, R. Willem,
J. Organomet. Chem. 582 (1999) 195;
E.R.T. Tiekink, J. Organomet. Chem. 408 (1991) 323.
[37] B.N. Meyer, N.R. Ferrigni, J.E. Putnam, L.B. Jacobsen, D.E. Nicholas, J.L. McLaughlin,
J. Planta Medica 45 (1982) 31.
[38] G. Barone, A. Silvestri, G. Ruisi, G. La Manna, Chem. Eur. J. 11 (2005) 6185.
[39] M. Gielen, A. El Khloufi, M. Biesemans, M. Mahieu, R. Willem, Bull. Soc. Chim. Belg.
101 (1992) 243.
[40] [a] F.J. Emele, J. Shanman, Proc. Soc. Exptl. Biol. Med. 114 (1963) 680;
[b] S.K. Hadjikakou, M.A. Demertzis, J.R. Miller, D. Kovala-Demertzi, J. Chem. Soc.
Dalton Trans. (1999) 663.
[41] R. Willem, H. Dalil, M. Biesemans, J.C. Martins, M. Gielen, Appl. Organomet. Chem.
13 (1999) 605 C.
[42] N.A. Al Aziz, R.M. Shehata, M.A.M. Mahmoud, M.M. Shoukry, Main Group Met.
Chem. 2 (1999) 253.
[43] E.C. Holloway, M. Melnik, Main Group Met. Chem. 23 (2000) 331.
[44] K.C. Molloy, K. Quill, J. Nowell, Chem. Soc. Dalton Trans. (1987) 101.
[45] S.W. Ng, A.J. Kuthbutheen, V.G.K. Lindens, E.R.T. Tiekink, Appl. Organomet. Chem.
8 (1994) 37.
[46] K. Ramesh, G. Anand, K. Pratibha, V. Paloth, Main Group Met. Chem. 25 (2002)
637.
[47] A.G. Davies, J.P. Goddard, M.B. Hursthouse, N.P.C. Walker, J. Chem. Soc. Chem.
Commun. (1983) 597.
[48] M. Gielen, A. Bouhdid, E.R.T. Tiekink, D. de Vos, R. Willem, Met. Based Drugs 3 (2)
(1996) 75.